135 related articles for article (PubMed ID: 37548593)
1. Heterogeneity in practitioner-reported barriers to use, cost considerations and priorities for point of care sexually transmitted infection tests on surveys across seven years.
Tuddenham S; Hsieh YH; Manabe YC; Gaydos CA; Rompalo A
Int J STD AIDS; 2023 Dec; 34(14):1012-1017. PubMed ID: 37548593
[TBL] [Abstract][Full Text] [Related]
2. Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings.
Khumalo F; Passmore JS; Manhanzva M; Meyer B; Duyver M; Lurie M; Tanko RF; Masson L
Curr Opin Infect Dis; 2023 Feb; 36(1):49-56. PubMed ID: 36753705
[TBL] [Abstract][Full Text] [Related]
3. What qualities are most important to making a point of care test desirable for clinicians and others offering sexually transmitted infection testing?
Hsieh YH; Gaydos CA; Hogan MT; Uy OM; Jackman J; Jett-Goheen M; Albertie A; Dangerfield DT; Neustadt CR; Wiener ZS; Rompalo AM
PLoS One; 2011 Apr; 6(4):e19263. PubMed ID: 21559435
[TBL] [Abstract][Full Text] [Related]
4. A novel point-of-care testing strategy for sexually transmitted infections among pregnant women in high-burden settings: results of a feasibility study in Papua New Guinea.
Badman SG; Vallely LM; Toliman P; Kariwiga G; Lote B; Pomat W; Holmer C; Guy R; Luchters S; Morgan C; Garland SM; Tabrizi S; Whiley D; Rogerson SJ; Mola G; Wand H; Donovan B; Causer L; Kaldor J; Vallely A
BMC Infect Dis; 2016 Jun; 16():250. PubMed ID: 27268218
[TBL] [Abstract][Full Text] [Related]
5. Facilitators and barriers to point-of-care testing for sexually transmitted infections in low- and middle-income countries: a scoping review.
Martin K; Wenlock R; Roper T; Butler C; Vera JH
BMC Infect Dis; 2022 Jun; 22(1):561. PubMed ID: 35725437
[TBL] [Abstract][Full Text] [Related]
6. Sexually Transmitted Infection Co-testing in a Large Urban Emergency Department.
Ford JS; Morrison JC; Wagner JL; Nangia D; Voong S; Matsumoto CG; Chechi T; Tran N; May L
West J Emerg Med; 2024 May; 25(3):382-388. PubMed ID: 38801045
[TBL] [Abstract][Full Text] [Related]
7. Bridging the gap between development of point-of-care nucleic acid testing and patient care for sexually transmitted infections.
Hsieh K; Melendez JH; Gaydos CA; Wang TH
Lab Chip; 2022 Feb; 22(3):476-511. PubMed ID: 35048928
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing sexually transmitted infections in resource-constrained settings: challenges and ways forward.
Wi TE; Ndowa FJ; Ferreyra C; Kelly-Cirino C; Taylor MM; Toskin I; Kiarie J; Santesso N; Unemo M
J Int AIDS Soc; 2019 Aug; 22 Suppl 6(Suppl Suppl 6):e25343. PubMed ID: 31468679
[TBL] [Abstract][Full Text] [Related]
9. Acceptability, feasibility and cost of point of care testing for sexually transmitted infections among South African adolescents where syndromic management is standard of care.
Marcus R; C P; Gill K; Smith P; Rouhani S; Mendelsohn A; Mendel E; Lince-Deroche N; Naidoo K; Ahmed N; Stirrup O; Roseleur J; Leuner R; Meyer-Rath G; Bekker LG
BMC Health Serv Res; 2023 Oct; 23(1):1078. PubMed ID: 37817160
[TBL] [Abstract][Full Text] [Related]
10. A Pilot of Mail-Out HIV and Sexually Transmitted Infection Testing in Washington, District of Columbia During the COVID-19 Pandemic.
Fistonich GM; Troutman KM; Visconti AJ
Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S16-S25. PubMed ID: 34686285
[TBL] [Abstract][Full Text] [Related]
11. Scaling Up CareKit: Lessons Learned from Expansion of a Centralized Home HIV and Sexually Transmitted Infection Testing Program.
Norelli J; Zlotorzynska M; Sanchez T; Sullivan PS
Sex Transm Dis; 2021 Aug; 48(8S):S66-S70. PubMed ID: 34030160
[TBL] [Abstract][Full Text] [Related]
12. Modelling-based evaluation of the costs, benefits and cost-effectiveness of multipathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary medicine clinic attendees.
Huntington SE; Burns RM; Harding-Esch E; Harvey MJ; Hill-Tout R; Fuller SS; Adams EJ; Sadiq ST
BMJ Open; 2018 Sep; 8(9):e020394. PubMed ID: 30201794
[TBL] [Abstract][Full Text] [Related]
13. Provider uptake of extragenital screening for gonorrhea and chlamydia in a cohort of Air Force members with incident HIV diagnosis.
Yabes J; Lamb CC; Hakre S; Scott PT; Mika W; Okulicz JF
Medicine (Baltimore); 2022 Oct; 101(42):e31209. PubMed ID: 36281093
[TBL] [Abstract][Full Text] [Related]
14. Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low- and middle-income countries.
Garrett NJ; Osman F; Maharaj B; Naicker N; Gibbs A; Norman E; Samsunder N; Ngobese H; Mitchev N; Singh R; Abdool Karim SS; Kharsany ABM; Mlisana K; Rompalo A; Mindel A
PLoS One; 2018; 13(4):e0196209. PubMed ID: 29689080
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the burden of self-reported bacterial sexually transmitted infections among men having sex with men across 68 countries on four continents.
Marcus U; Veras M; Casabona J; Caceres CF; Lachowsky N; Schink SB; Schmidt AJ
BMC Public Health; 2023 May; 23(1):1008. PubMed ID: 37254096
[TBL] [Abstract][Full Text] [Related]
16. Is it time to use nucleic acid amplification tests for identification of persons with sexually transmitted infections?: evidence from seroprevalence and behavioral epidemiology risk surveys in men with chlamydia and gonorrhea.
Tobin L; Guerra L; Ahouanvoeke L; Carpio JG; Irambona D; Nyarko EO; Macera C; Wiersma S
Pan Afr Med J; 2020; 36():299. PubMed ID: 33117493
[TBL] [Abstract][Full Text] [Related]
17. Perceptions of an ideal point-of-care test for sexually transmitted infections--a qualitative study of focus group discussions with medical providers.
Hsieh YH; Hogan MT; Barnes M; Jett-Goheen M; Huppert J; Rompalo AM; Gaydos CA
PLoS One; 2010 Nov; 5(11):e14144. PubMed ID: 21152386
[TBL] [Abstract][Full Text] [Related]
18. Chlamydia, Gonorrhea, and Human Immunodeficiency Virus Infection Among Transgender Women and Transgender Men Attending Clinics that Provide Sexually Transmitted Disease Services in Six US Cities: Results From the Sexually Transmitted Disease Surveillance Network.
Pitasi MA; Kerani RP; Kohn R; Murphy RD; Pathela P; Schumacher CM; Tabidze I; Llata E
Sex Transm Dis; 2019 Feb; 46(2):112-117. PubMed ID: 30278030
[TBL] [Abstract][Full Text] [Related]
19. Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial.
Asare K; Andine T; Naicker N; Dorward J; Singh N; Spooner E; Andriesen J; Osman F; Ngcapu S; Vandormael A; Mindel A; Abdool Karim SS; Bekker LG; Gray G; Corey L; Tomita A; Garrett N
Clin Infect Dis; 2023 Mar; 76(5):881-889. PubMed ID: 36250382
[TBL] [Abstract][Full Text] [Related]
20. Call to action for health systems integration of point-of-care testing to mitigate the transmission and burden of sexually transmitted infections.
Toskin I; Govender V; Blondeel K; Murtagh M; Unemo M; Zemouri C; Peeling RW; Kiarie J
Sex Transm Infect; 2020 Aug; 96(5):342-347. PubMed ID: 32241905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
